After liver transplantation for Budd–Chiari in patients with persistent high-risk thrombophilia (e.g., MPN/APS/PNH) and prior splanchnic thrombosis extension, what is your standard long-term anticoagulation strategy and what objective findings prompt you to intensify or de-escalate it?